Please provide your email address to receive an email when new articles are posted on . Psoriasis patients who self-administer bimekizumab experienced similar levels of comfort and success with both ...

IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. Herbert Busher, a physician in St ...

Industry first single-use auto-injector for both 1ml and 2.25 pre-filled syringes with versatile design for different fill volumes in the same device. Aidaptus has an innovative, patient-centric ...

The new Syrina 2.25 is a compact auto-injector that uses the standard 2.25 mL prefilled syringe, based on Bespak’s proprietary VapourSoft technology. Drug-delivery company, Bespak, is launching its ...

The two companies signed an exclusive collaboration agreement for the Aidaptus auto-injector. Owen Mumford, a medical device manufacturer, announced on May 4, 2022 that it has signed an exclusive ...

The auto injector market represents a rapidly expanding segment within the global pharmaceutical delivery systems industry, driven by the increasing prevalence of chronic diseases and the growing ...

The patients suffering from chronic disease require a regular dose of medicines, either orally or as injections. The patients prefer the self-injection method as it is easy to use, cost-effective, and ...

In its heated severe asthma fight with AstraZeneca’s Fasenra, GlaxoSmithKline could take solace in the fact that its drug was more convenient for patients, with a self-administered injection option.

Dublin, Nov. 10, 2020 (GLOBE NEWSWIRE) -- The "Epinephrine Auto-Injector Market by Age group, Dosage, by End-user, and Geography - Global Drivers, Restraints, Opportunities, Trends, and Forecast up to ...